Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Two of 11 people who received four doses of budigalimab maintained viral suppression for a year and a half after stopping antiretrovirals.
People who used once-weekly oral lenacapavir maintained viral suppression when injections were interrupted.
Latent HIV may hide in a distinct reservoir in the brain and spinal cord.
One new approach protects CD4 cells against HIV entry, while another snips out viral genes in infected cells.
Different mechanisms suppressed the virus in each person.
Scientists are getting a better sense of the risks and benefits of treatment interruptions in cure research.
After my treatment interruption I’m... undetectable, in every way. Untransmittable, that’s how I’ll stay (hopefully!).
HTI vaccines could become the backbone of a combination approach for achieving a functional cure.
An analysis looked at the way HIV rebounds during treatment interruptions based on the age of the antiretrovirals used.
This raises concerns that men with HIV participating in cure and therapeutic vaccine studies may transmit the virus.
A new study found that 44% of Medicaid enrollees with HIV who stopped antiretroviral treatment did not restart therapy within 18 months.
According to a survey, many people with HIV don’t understand how cure trials work.
A new study found that 44% of such individuals who stopped antiretroviral treatment did not restart therapy within 18 months.
Previous research has shown that long interruptions are not safe—but what about shorter, more closely monitored gaps in treatment?
Many HIV cure trials take participants off antiretrovirals for a period in order to see how well the investigational treatment works.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.